nOCT Imaging System
Visualization during endovascular treatment of brain aneurysms
Pivotal TrialActive
Key Facts
Indication
Visualization during endovascular treatment of brain aneurysms
Phase
Pivotal Trial
Status
Active
Company
About Spryte Medical
Spryte Medical is pioneering intravascular imaging for the neurovascular space with its nOCT platform, which offers >10x the resolution of current angiography systems to visualize vessel walls, pathology, and implanted devices. The company has achieved significant milestones, including FDA Breakthrough Device Designation, IDE approval for a pivotal US trial (INSYTE), and first-in-human publications in high-impact journals. Positioned at the intersection of medical devices and AI, Spryte aims to become a standard-of-care imaging tool for neurointerventionalists treating aneurysms, stroke, and intracranial atherosclerosis.
View full company profile